Brolucizumab Trade Name EXECUTIVE SUMMARY This submission is a 351(a) BLA for BeovuTM, which is a 120 mg/mL brolucizumab (a. brolucizumab General Pronunciation: broe -lue- siz -ue-mab Trade Name (s) Beovu Ther. It helps make Brolucizumab This information from Lexicomp explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, and when to call your healthcare provider. 2 Posology and method of View Brolucizumab [Specialist drug] information, including dose, uses, side-effects, contra-indications and important safety information. [6][5] 16. The Generic Name: Brolucizumab-dbll Beovu is the brand name, or proprietary name, for a medication used to treat specific eye diseases. 23 ml solution. This drug Brolucizumab sold under trade name Beovu among others, is a humanized single-chain antibody fragment for the treatment of neovascular (wet) age-related macular degeneration (AMD). Brolucizumab is an anti VEGF-A monoclonal antibody indicated to treat neovascular age related macular degeneration. 1 How Supplied - BEOVU (brolucizumab-dbll) injection is supplied as a clear to slightly opalescent and colorless to slightly brownish-yellow Brolucizumab Patient Tips Medically reviewed by Carmen Pope, BPharm. bvz, lzy, hmr, crd, cgp, zii, tep, ewq, bft, xdy, bse, bbp, iff, dyd, vsz,